DNAlite Therapeutics, Inc. is an early-stage preclinical biotechnology company committed to creating a category of medicines overcoming constraints of current biological medicines.
ORAL and repeatable Administration
Powered by a proprietary vector technology, all of DNAlite’s medicines are designed to be oral and non-immunogenic; overcoming the shortcomings of current biologics.
Treating the Cause of GI diseaseS
DNAlite is modifying the GI tract to restore its abilities in patients with genetic diseases or with compromised mucosa.
We are harnessing our vector technology to carry DNA/RNA to the GI cells to fight intestinal and systemic diseases